The Cigna Group Foundation Offers $250K Grants to Memphis Nonprofits for Health Care Access
Cigna Foundation Offers $250K in Grants to Memphis Nonprofits to Expand Health Care Access The The Cigna Group Foundation has announced a significant expansion of its Impact Fund to Memphis, reinforcing its long-standing commitment to improving community health outcomes across…
United Healthcare Cuts Prior Authorizations, Speeds Rural Provider Payments
UnitedHealthcare Eases Prior Authorizations, Speeds Payments for Rural Providers Nationwide UnitedHealthcare has unveiled a sweeping expansion of its rural health care strategy, introducing a set of nationwide initiatives aimed at strengthening independent rural hospitals, easing administrative burdens, and improving access…
SBC Medical Prices 3.1M-Share Secondary Stock Offering
Secondary Offering of 3.1M Shares Priced at $3.25 Each by Selling Stockholder SBC Medical Group Holdings Incorporated has announced the pricing of an underwritten secondary public offering involving 3.1 million shares of its common stock. The transaction, disclosed in an…
Synthetic Design Lab Debuts Logic-Gated ADC with 10x Boost in Cancer Cell Targeting
Synthetic Design Lab Debuts First Logic-Gated ADC at AACR 2026, Showing Over 10X Boost in Cancer Cell Killing Synthetic Design Lab has unveiled a bold new direction in the field of biologic therapeutics with the introduction of its SYNTHBODY™ platform—a…
Lundbeck Shares AAN 2026 Data on Cognitive Symptom Improvement with VYEPTI in Migraine Patients
Lundbeck Shares AAN 2026 Data Showing Real-World Cognitive Improvements in Migraine Patients Treated with VYEPTI Lundbeck today presented new real-world 6-month results from the INFUSE study at the American Academy of Neurology (AAN) 2026 Annual Meeting, underscoring the importance of evaluating the…
Definium Therapeutics Backs White House Push for Psychedelic Mental Health Treatments
Definium Therapeutics Supports White House Order to Advance Psychedelic Mental Health Treatments Definium Therapeutics a late-stage clinical biopharmaceutical company focused on addressing the root causes of psychiatric and neurological disorders, has publicly expressed its support for a newly signed White…
Inocras & Broad Institute Reveal New TCGA Cancer Genome Insights
Inocras & Broad Institute Unveil New TCGA Whole-Genome Insights to Advance Cancer Genomics Researchers from Inocras and the Broad Institute of MIT and Harvard are set to unveil significant new findings from one of the most extensive whole-genome cancer analyses…
Compass Pathways Applauds White House Order to Fast-Track Psychedelic Research and Access
Compass Pathways Backs White House Initiative to Accelerate Psychedelic Treatments for Mental Health Compass Pathways plc a biotechnology company focused on expanding access to evidence-based mental health innovations, has expressed strong support for a recent White House Executive Order aimed…
HSS Highlights AI-Driven Pain Risk Insights and Anesthesia Education Research at ASRA Meeting
HSS Research Highlights AI’s Growing Role in Predicting Pain Risk and Improving Anesthesia Education At the American Society of Regional Anesthesia and Acute Pain Medicine (ASRA) annual meeting, researchers from Hospital for Special Surgery (HSS) unveiled new findings demonstrating how…
Zai Lab Highlights ZL-1503’s Rapid Itch Relief and Anti-Inflammatory Potential in Atopic Diseases
Zai Lab Showcases ZL-1503’s Rapid Itch Relief and Anti-Inflammatory Effects in Atopic Diseases Zai Lab Limited has unveiled new preclinical findings highlighting the therapeutic promise of ZL-1503, an investigational bispecific antibody designed to simultaneously target IL-13 and IL-31Rα pathways. The…
My Mountain Mover Expands into Dental with Virtual Assistants Built for Practice Operations
My Mountain Mover Expands Into Dental Industry With Specialized Virtual Assistant Training Program My Mountain Mover (MMM), a recognized leader in providing Medical Virtual Assistants to healthcare practices across the United States, has announced its official expansion into the dental…
Soley Therapeutics Reports Selective Anti-Tumor Activity of STX-6398 at AACR 2026
Soley Therapeutics Unveils Preclinical AACR 2026 Data Highlighting Selective Anti-Tumor Activity of First-in-Class CKAP2 Modulator STX-6398 Soley Therapeutics, a biotechnology company focused on developing innovative therapies rooted in integrated cell stress biology, has announced the presentation of new preclinical findings…